NCT03631056|Unknown
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries
1 other identifier
CLN-EA-IP
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredAug 2018
Brief Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options and are not eligible for an ATEV clinical study
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2018
Completed5 days until next milestone
First Posted
Study publicly available on registry
August 15, 2018
CompletedLast Updated
August 24, 2025
Status Verified
August 1, 2025
First QC Date
August 10, 2018
Last Update Submit
August 19, 2025
Conditions
Interventions
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Humacyte, Inc.lead
MeSH Terms
Conditions
Vascular System Injuries
Condition Hierarchy (Ancestors)
Vascular DiseasesCardiovascular DiseasesWounds and Injuries
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2018
First Posted
August 15, 2018
Last Updated
August 24, 2025
Record last verified: 2025-08